ATX-304 (O-304)

InvestigationalMetabolic Small MoleculeWeight & metabolicLongevity & cellular

Awaiting review, BioHarmony verdict

Not yet scored. Queued for review; until then rely on the status and sources below.

What is ATX-304 (O-304)?

Amplifier Therapeutics describes ATX-304, also known as O-304, as an oral small-molecule pan-AMPK activator in Phase 2 development. It is frequently marketed in peptide catalogs but is not a peptide.

Saved on this device only.

Dosing as published

Source-reported figures only. This page does not calculate a personal dose.

No approved-label or study protocol is recorded for ATX-304 (O-304) yet.

More reported protocols

Members

Members can compare additional reported doses, schedules, and preparation notes.

Educator coverage (2)

Attributed viewpoints, separate from primary research.

Trust & sourcing

  1. Last revieweddone
  2. Next reviewupcoming
US approvalInvestigational
CompoundingEligibility not established.

Primary sources

The Ultimate Peptides Guide

Spot stronger candidates, weak evidence, and seller red flags before you buy.

Free. Includes evidence and regulatory updates. Unsubscribe anytime.